BCIQ Profiles

Company Profile Report
0702 2Q21 Wrap
BioCentury & Getty Images

2Q21 Wrap

2Q21 Wrap: IPOs lead the way

With biotech stocks mostly flat in 2Q21, IPOs were top performers

Winners, losers in biotech stock tiers in 2Q21.

Jul 3, 2021 | 3:26 AM GMT

Biotech stocks across all market cap tiers were mostly flat in 2Q21, with only one large cap achieving a major gain, microcaps falling a median of 4% and three middle market cap tiers hobbling along with gains of less than 1% each. Recent IPOs, and in particular IPOs by companies from China, accounted for many of the quarter’s top performers.

For large caps — defined as companies starting the quarter with valuations

Read the full 1117 word article

How to gain access

Continue reading with a
two-week free trial.